The analysis was conducted on ERα+ or ERα− BC patients subgroups and revealed a strong correlation between FoxO3a and integrin α5 mRNA expression only in patients with ERα+ BC, while the correlation was lost in ERα− BC patients (Figure 3i). This evidence concerns the gene FOXO3 and breast cancer.